Liu et al. revealed that treatment with exosomes released by EGFR TKI-resistant lung cancer cells resulted in the acquisition of resistance in TKI-sensitive cells via phosphoinositide 3-kinase (PI3K)/AKT signaling pathway activation, suggesting a potential contribution of exosomes to the emergence of TKI resistance [143]. The gene discussed is EGFR; the disease is lung carcinoma.